相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rd English edition
Masaru Miyazaki et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets
Andrew X. Zhu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
Chaitanya R. Churi et al.
PLOS ONE (2014)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo et al.
ONCOTARGET (2014)
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
Jesse S. Voss et al.
HUMAN PATHOLOGY (2013)
The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome
Scott Robertson et al.
HUMAN PATHOLOGY (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
Michele Simbolo et al.
PLOS ONE (2013)
ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
Kyun Woo Park et al.
CANCER RESEARCH AND TREATMENT (2013)
IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications
Darrell R. Borger et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality
Alberto Zamo et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients
Rui Feng Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies
Juan Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Cholangiocarcinoma-controversies and challenges
Tushar Patel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
The concept of perihilar cholangiocarcinoma is valid
T. Ebata et al.
BRITISH JOURNAL OF SURGERY (2009)
Prognosis of perihilar cholangiocarcinoma: Hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus
Tsuyoshi Sano et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Immunohistochemical study of DPC4 and P53 proteins in gallbladder and bile duct cancers
SC Chuang et al.
WORLD JOURNAL OF SURGERY (2004)
分享论文
